Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Recruiting
N/A
Interventional Study
Bladder Cancer
Muscle Invasive Bladder Cancer (MIBC)
Muscle Invasive Bladder Cancer Urothelial Carcinoma
Cystectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 130 (estimated)
- Sponsor
- Johns Hopkins University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Radical cystectomy is the standard of care for muscle invasive bladder cancer, however despite advances, it is still associated with high morbidity. Many complications may be driven by dehydration and it is unclear if a home intravenous fluid (IVF) infusion program post-operatively, which is an accepted standard practice, is beneficial. This study is a single institution randomized controlled tria…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients greater than 18 years of age and older
* Confirmed urothelial carcinoma on pathology, including muscle invasive, non-muscle invasive, and variant histology
* Patient electing to undergo radical cystectomy with bilateral pelvic lymphadenectomy after counseling wi…
Contacts